Free Trial

NextCure (NXTC) News Today

$1.62
-0.05 (-3.28%)
(As of 12:39 PM ET)
NextCure, Inc. (NASDAQ:NXTC) Short Interest Update
NextCure, Inc. (NASDAQ:NXTC - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 839,700 shares, a growth of 579.9% from the February 29th total of 123,500 shares. Based on an average daily trading volume, of 229,500 shares, the short-interest ratio is presently 3.7 days. Approximately 4.0% of the company's stock are sold short.
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
HC Wainwright Boosts NextCure (NASDAQ:NXTC) Price Target to $8.00
HC Wainwright boosted their price target on NextCure from $5.00 to $8.00 and gave the company a "buy" rating in a research note on Friday.
NextCure Provides Year-End Clinical Pipeline Updates
NextCure Inc NXTC
NextCure Inc (NXTC) Reports Q3 2023 Financial Results
NextCure (NASDAQ: NXTC)
Get NextCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.

Little-known biotech company just had groundbreaking results from a study (Ad)

Learn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!

Click here for the full report & ticker symbol

NXTC Media Mentions By Week

NXTC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NXTC
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

NXTC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NXTC Articles
This Week

0

1

NXTC Articles
Average Week

Get NextCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NXTC) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners